$BMRN, $ILMN, $NOC, $SIG, $SQ
Below is a list of Wall Street’s Top analysts outlook for Key issues for Wednesday, as follows:
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) was reiterated as Buy and the price target was raised to 113 from 105 at Canaccord Genuity. Shares trade in a 52-wk range of 75.81 – 104.46.
Illumina Inc. (NASDAQ:ILMN) was reiterated as Buy and the price target was raised to 340 from 330. Deutsche Bank also reiterated its Buy rating and raised its target to 330 from 280.
Northrop Grumman Corp. (NYSE:NOC) was raised to Buy from Neutral and the price target was raised to 371 from 246 at Buckingham Research.
Signet Jewelers Ltd. (NYSE:SIG) was downgraded to Neutral from Buy at Nomura.
Square Inc. (NYSE: SQ) was maintained as Buy and the price target was raised to 72 from 66 at Stifel.
Latest posts by Paul Ebeling (see all)
- The Street’s Key Stock Analysts Research Reports - November 21, 2019
- Gold Price Outlook: Gold Set Up for a Holiday Rally - November 21, 2019
- Men Maintaining Muscle Mass in Middle-age May Lower Risk of Heart Disease - November 21, 2019